Big challenges spark big ideas. In Where Next Happens, Dr. Claudia Krywiak talks with Ontario’s innovators—founders, researchers, and changemakers—turning bold solutions into impact across healthcare, climate, housing, and beyond.Brought to you by the Ontario Centre of Innovation.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Where Next Happens
Claim This Podcastby Ontario Centre of Innovation
9 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇨🇦
Podcast Overview
Big challenges spark big ideas. In Where Next Happens, Dr. Claudia Krywiak talks with Ontario’s innovators—founders, researchers, and changemakers—turning bold solutions into impact across healthcare, climate, housing, and beyond.Brought to you by the Ontario Centre of Innovation.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
10/2/2025
1 verified contact email on file for Where Next Happens
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
December 10, 2025
Reinventing Home Care (Chenny Xia and Gotcare)
<p>Dr. Claudia Krywiak interviews CEO and co-founder of Gotcare Chenny Xia about the challenges and innovations in Canada’s home care system. Chenny discusses Gotcare’s technology-driven, human-centered platform that empowers patients and caregivers, improves access tohome care, and supports care workers. The conversation covers the importance of co-design, the thoughtful use of AI, and Gotcare’s efforts to upskill workers and foster multidisciplinary collaboration.</p><br><p><strong>About Chenny Xia</strong></p><p>Chenny Xia is the CEO and co-founder of Gotcare, a Canadian health technology company reimagining home care delivery. Gotcare connects patients with local care workers while improving working conditions and wages for caregivers. Chenny brings a background in human-centred design and innovation strategy, with experience spanning healthcare, technology, and social impact. She’s passionate about creating equitable systems that allow everyone to age with dignity and independence.</p><br><p><strong>Resources Mentioned / Links List</strong></p><p>Ontario Centre of Innovation: oc-innovation.ca/podcast</p><p>Gotcare: https://gotcare.ca/</p><br><p><strong>Enjoyed this Episode?</strong></p><p>If you did, be sure to subscribe and share it with your friends! Where Next Happens is a podcast that explores bold ideas, breakthrough research, and entrepreneurial journeys shaping Ontario’s future. Post a review and share it! </p><p>If you enjoyed this episode, please leave us a review. Share it with friends and colleagues. Let's inspire everyone to innovate! </p><p>Find out more about the Ontario Centre of Innovation at <a href="https://about:blank/">https://www.https://www.oc-innovation.ca/</a> </p><p>Thank you for tuning in!</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
December 3, 2025
Revolutionizing Fertility and Family Planning (Jeremy Grushcow & Kaylene Ready, Juniper Genomics)
<p>This episode of Where Next Happens delves into the future of reproductive health with Jeremy Grushcow (CEO & Co-Founder) and Kaylene Ready (Chief Product Officer & Genetic Counsellor) of Juniper Genomics. Host Doctor Claudia Krywiak explores the shift towards later parenthood, the challenges of fertility decline, and how Juniper Genomics’ cutting-edge genetic testing is changing IVF outcomes and patient experiences. </p><br><p><strong>About Jeremy Grushcow and Kaylene Ready </strong></p><p><strong>Jeremy Grushcow</strong> co-founded Juniper Genomics to improve IVF outcomes and launched the world’s first whole genome and transcriptome embryo test in US and Canadian clinics. He holds a Ph.D. in Molecular Genetics and Cell Biology and a J.D. from the University of Chicago, with experience at Cyclica and Sequence Bio.</p><p><strong>Kaylene Ready</strong> is a genetic counsellor and Chief Product Officer at Juniper Genomics, where she develops innovative genomic testing and digital health solutions. She holds an M.S. in Genetic Counselling from the University of Texas.</p><br><p><strong>Resources Mentioned / Links List </strong></p><ul><li>Ontario Centre of Innovation: <a href=" https://www.oc-innovation.ca/" target="_blank" rel="noopener noreferer">https://www.oc-innovation.ca/</a></li><li>Jupiter Genomics: <a href="https://www.junipergenomics.com/" target="_blank" rel="noopener noreferer">https://www.junipergenomics.com/</a></li></ul><p><br></p><p><strong>Enjoyed this Episode?</strong></p><p>If you did, be sure to subscribe and share it with your friends! Where Next Happens is a podcast that explores bold ideas, breakthrough research, and entrepreneurial journeys shaping Ontario’s future. Post a review and share it! </p><p>If you enjoyed this episode, please leave us a review. Share it with friends and colleagues. Let's inspire everyone to innovate! </p><p>Find out more about the Ontario Centre of Innovation at <a href="https://about:blank/" target="_blank" rel="ugc noopener noreferrer">https://www.https://www.oc-innovation.ca/</a> </p><p>Thank you for tuning in!</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
November 26, 2025
Wearable Technology Meets Critical Care (Joe Eibl and Flosonics Medical)
<p>Ontario sees 1 in 6 hospitalizations involve sepsis—a critical condition where time and monitoring make all the difference. In this compelling episode, Dr. Claudia Kreviazuk sits down with Dr. Joe Eibl, co-founder of Flosonics Medical, creators of the FloPatch: the world’s first wearable, wireless ultrasound device for real-time, non-invasive blood flow monitoring in critically ill patients. Dr. Eibl shares the personal story that sparked this innovation, the challenges and strategies of bringing a breakthrough medical device to market, and what’s on the horizon for predictive, data-driven critical care. </p><br><p><strong>About Joe Eibl </strong></p><p>Dr. Joseph Eibl is co-founder and CEO of Flosonics Medical, a Sudbury-based medtech startup developing the FloPatch, a wearable ultrasound bandage that helps clinicians monitor patients at risk of sepsis in real time. He holds a PhD in Biomolecular Sciences, completed postdoctoral training in bioengineering, and leads the company’s technology, IP, and business strategy. </p><br><p><strong>Resources Mentioned / Links List </strong></p><ul><li><p>Ontario Centre of Innovation: <a href="https://www.oc-innovation.ca/" target="_blank" rel="ugc noopener noreferrer">https://www.oc-innovation.ca/</a> </p></li></ul><ul><li><p>Flosonics Medical: <a href="https://flosonicsmedical.com/" target="_blank" rel="ugc noopener noreferrer">https://flosonicsmedical.com/</a> </p></li></ul><p><strong>Enjoyed this Episode? </strong></p><p>If you did, be sure to subscribe and share it with your friends! Where Next Happens is a podcast that explores bold ideas, breakthrough research, and entrepreneurial journeys shaping Ontario’s future. Post a review and share it! </p><p>If you enjoyed this episode, please leave us a review. Share it with friends and colleagues. Let's inspire everyone to innovate! </p><p>Find out more about the Ontario Centre of Innovation at <a href="https://about:blank/" target="_blank" rel="ugc noopener noreferrer">https://www.https://www.oc-innovation.ca/</a> </p><p>Thank you for tuning in!</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
9 total episodes available
Deep-dive analytics for Where Next Happens
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Where Next Happens?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.